Comment on 'Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK'
- PMID: 25190531
- PMCID: PMC4268452
- DOI: 10.1038/eye.2014.204
Comment on 'Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK'
Comment in
-
Response to Dr Clearkin.Eye (Lond). 2014 Dec;28(12):1523. doi: 10.1038/eye.2014.205. Epub 2014 Sep 5. Eye (Lond). 2014. PMID: 25190530 Free PMC article. No abstract available.
Comment on
-
Herpes zoster ophthalmicus reduction: implementation of shingles vaccination in the UK.Eye (Lond). 2014 Mar;28(3):247-8. doi: 10.1038/eye.2013.303. Eye (Lond). 2014. PMID: 24622628 Free PMC article. No abstract available.
References
-
- Herbort CP, Buechi ER, Piguet B, Zografos L, Fitting P. High-dose oral acyclovir in acute herpes zoster ophthalmicus: the end of the corticosteroid era. Curr Eye Res. 1991;10 (Suppl:171–175. - PubMed
-
- Dworkin RH, Schmader KE. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis. 2003;36 (7:877–882. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
